Some of the major ophthalmic viscosurgical devices (OVD) market players include Alcon, CIMA Technology, Bausch & Lomb, Amring Pharmaceuticals, Bohus Biotech AB and Maxigen Biotech among others.

Could there finally be a surgical treatment for Glaucoma that works as well as drops, but without the risks of traditional surgery. According to a recent study, the answer is "Yes."